Thrombectomy Devices Market Report 2025 (Global Edition)

Global Thrombectomy Devices Market Report 2025 Market Size Split by Type Outlook: (Aspiration Devices, Mechanical Devices, Ultrasonic Devices, Other Thrombectomy Devices), by Application Outlook: (Car...

Thrombectomy Devices Market Report Description

We have various report editions of Thrombectomy Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Thrombectomy Devices Market Insights Video

Competitive Landscape of the Thrombectomy Devices Market

In the competitive landscape of the Thrombectomy Devices market, several important competitors compete for market share and innovation. These firms provide a variety of thrombectomy devices meant to remove blood clots from arteries and veins, improving patient outcomes in situations such as stroke and deep vein thrombosis. The market is very competitive, with businesses investing in R&D to introduce enhanced thrombectomy devices with higher efficacy and safety profiles.

February, 2024, Endovascular Engineering Inc., one of the leading medical device firms advancing clot removal solutions for venous thromboembolism (VTE), has announced the enrollment and treatment of the first patient in the pivotal phase of its ENGULF US clinical study. This IDE experiment will assess the effectiveness and safety of the H?lo PE thrombectomy system, a new method for treating pulmonary embolism (PE). (Source: https://www.financialexpress.com/business/healthcare-am-naik-madhusudan-kela-others-invest-in-s3v-vascular-technologies-3425759/) March 2024, L&T chairman emeritus A M Naik, investors such as Madhusudan Kela and Utpal Sheth, and other high-net-worth individuals have invested in medical device company S3V Vascular Technologies Ltd to assist it in establishing a facility for developing neurovascular devices to treat strokes. (Source: https://evtoday.com/news/endovascular-engineerings-helo-thrombectomy-system-receives-ide-approval-for-engulf-pivotal-trial-to-treat-pe

March 2024 - L&T chairman emeritus A M Naik, investors like Madhusudan Kela and Utpal Sheth, and other high net worth individuals have invested in medical devices company S3V Vascular Technologies Ltd to assist it in establishing a facility that will design neurovascular devices to treat stroke.
 (Source: - https://www.livemint.com/companies/a-m-naik-madhusudan-kela-invest-in-med-tech-firm-s3v-11710417439664.html )

February 2022 - Cernuous, a member of Johnson & Johnson Medical Devices Companies, introduced EMBOGUARD, a next-generation balloon guide catheter for use in endovascular procedures, such as those for acute ischemic stroke patients.
 (Source:https://www.jnjmedtech.com/en-US/news-events/cerenovus-launches-emboguard-balloon-guide-catheter-use-treatment-acute-ischemic )
 

Top Companies Market Share in Thrombectomy Devices Industry: (In no particular order of Rank)

• Argon Medical Devices Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic Plc
• Penumbra Inc.
• Spectranetics Corporation (Koninklijke Philips N.V.)
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Thrombectomy Devices Market

Which Region Dominates the Thrombectomy Devices Market in 2024?

According to Cognitive Research, North America region dominated the market and accounted for the highest revenue of XX% in 2025 and it is projected that it will grow at a CAGR of XX% in the future. The increasing incidence of people undergoing heart attack and cardiac arrest, due to their busy lives and inactive lifestyle, is majorly propelling the thrombectomy devices market in North America. As a result, the increasing prevalence of chronic diseases is inflating the demand for thrombectomy devices, which is proving to be another key growth-driving factor. In addition, positive reimbursement environments for these devices and the growing healthcare sector are having a positive impact on the regional market. 

Which Region is Expanding at the Fastest CAGR?

Asia Pacific is projected to grow at a CAGR of XX% over the period. The key drivers for this Asia Pacific market are the rising geriatric population, which is contributing to a rise in cardiovascular diseases (CVDs) associated with patients, advancements in medical devices employed in capturing blood clots, and heightened awareness towards early disease diagnosis. The rise in the geriatric population is driving this market.

The current report Scope analyzes Thrombectomy Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Thrombectomy Devices Market Analysis

According to Cognitive Market Research, the global Thrombectomy Devices market size was estimated at USD 1654.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 661.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Thrombectomy Devices market with a market size of USD 522.07 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. In the US, the Thrombectomy Devices market is influenced by factors such as the prevalence of cardiovascular diseases.
• The Canada Thrombectomy Devices market had a market share of USD 79.40 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Canada's technological advancements.
• The Mexico Thrombectomy Devices market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 60.21 million in 2024.

Europe Thrombectomy Devices Market Analysis

According to Cognitive Market Research, the global Thrombectomy Devices market size was estimated at USD 1654.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 496.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

• The United Kingdom Thrombectomy Devices market had a market share of USD 83.37 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. In the UK, Thrombectomy Devices sales witness an upswing due to the nation's aging population.
• The France Thrombectomy Devices market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 45.66 million in 2024.
• According to Cognitive Market Research, the German Thrombectomy Devices market size was valued at USD 98.26 million in 2024 and is projected to grow at a CAGR of 5.7% during the forecast period. In Germany, Thrombectomy Devices surged due to increasing awareness of the benefits of thrombectomy procedures.
• The Italy Thrombectomy Devices market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 42.68 million in 2024.
• The Russia Thrombectomy Devices market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 76.92 million in 2024.
• The Spain Thrombectomy Devices market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD 40.69 million in 2024
• The Luxembourg Thrombectomy Devices market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 15.38 million in 2024.
• The Portugal Thrombectomy Devices market is projected to witness growth at a CAGR of 5.3% during the forecast period, with a market size of USD 10.42 million in 2024.
• The Greece Thrombectomy Devices market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 5.96 million in 2024.
• Rest of Europe's Thrombectomy Devices market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 76.92 million in 2024.

Asia Pacific Thrombectomy Devices Market Analysis

According to Cognitive Market Research, the global Thrombectomy Devices market size was estimated at USD 1654.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 380.47 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Thrombectomy Devices market size was valued at USD 171.21 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Thrombectomy Devices surged in China due to the prevalence of cardiovascular diseases
• The Japan Thrombectomy Devices market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 52.50 million in 2024.
• The India Thrombectomy Devices market had a market share of USD 45.66 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. India's aging population.
• The South Korean Thrombectomy Devices market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 38.05 million in 2024.
• The Australian Thrombectomy Devices market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD 19.78 million in 2024.
• The South East Asia Thrombectomy Devices market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 26.25 million in 2024.
• The Rest of Asia Pacific Thrombectomy Devices market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 27.01 million in 2024.

South America Thrombectomy Devices Market Analysis

According to Cognitive Market Research, the global Thrombectomy Devices market size was estimated at USD 1654.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 82.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Thrombectomy Devices market size was valued at USD 35.40 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Thrombectomy Devicess flourished in Brazil due to the country's robust healthcare infrastructure.
• Argentina's Thrombectomy Devices market had a market share of USD 13.90 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. Argentina's increasing investment in medical technology.
• Colombia Thrombectomy Devices market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 7.36 million in 2024.
• Peru Thrombectomy Devices market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 6.78 million in 2024.
• Chile Thrombectomy Devices market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 5.96 million in 2024.
• The Rest of Latin America's Thrombectomy Devices market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 13.32 million in 2024.

Middle East Thrombectomy Devices Market Analysis

According to Cognitive Market Research, the global Thrombectomy Devices market size was estimated at USD 1654.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 33.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031..

• The GCC Countries Thrombectomy Devices market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 14.16 million in 2024. Thrombectomy Devices sales flourish due to advancements in medical technology.
• The Egypt Thrombectomy Devices market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 3.47 million in 2024.
• The South Africa Thrombectomy Devices market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 5.23 million in 2024. Thrombectomy Devices sales flourish in South Africa due to increasing awareness about thrombectomy procedures.
• The Turkey Thrombectomy Devices market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 2.85 million in 2024.
• The Nigeria Thrombectomy Devices market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 3.47 million in 2024.
• The Rest of MEA Thrombectomy Devices market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 3.90 million in 2024.

Thrombectomy Devices Market Analysis

How are Segments Performing in the Global Thrombectomy Devices Market?

Thrombectomy Devices Market Type Segment Analysis

According to Cognitive Market Research, Aspiration devices have emerged as the most popular type in the worldwide thrombectomy device market. These devices provide a vacuum effect, which directly suctions the blood clot or thrombus from the afflicted blood vessel. The prominence of aspiration devices can be linked to their ability to remove blood clots and restore circulation quickly. Furthermore, they are quite simple to administer and have produced positive therapeutic outcomes. Healthcare providers are increasingly using aspiration devices to treat acute ischemic stroke and other vascular occlusions, which has contributed significantly to their market dominance.

Mechanical thrombectomy devices have emerged as the most rapidly developing type in the global market. These devices often use a mechanical mechanism, such as a revolving wire or a retriever, to physically fragment or trap the blood clot and remove it. Mechanical devices provide advantages such as accurate clot targeting, high clot retrieval rates, and shorter process times. The expanding body of clinical evidence supporting mechanical thrombectomy devices' efficacy, notably in the treatment of acute ischemic stroke, is driving their increased acceptance

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Thrombectomy Devices Industry. Request a Free Sample PDF!

Thrombectomy Devices Market Application Segment Analysis

According to Cognitive Market Research, Cardiovascular applications dominated the global market. Cardiovascular thrombectomy devices are designed to remove blood clots in the arteries or veins of the heart, which can cause illnesses such as heart attacks or deep vein thrombosis (DVT).

The neurovascular thrombectomy device sector is the fastest-growing application utilized to treat blood clots in the brain's blood arteries. It has shown substantial growth and advancement in recent years. These devices are used in operations like mechanical thrombectomy to treat ischemic strokes caused by blood artery blockages in the brain.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Thrombectomy Devices By End User Segment Analysis

• Hospitals and Surgical Centers
• Ambulatory Surgical Centers
• Research Laboratories & Academic Institutes
• Other End Users

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion